What is this nice shot made by the Lippens family?

Company

At the end of a final exercise (concluded at the end of March 2018), which proved unsatisfactory, the Finasucre Holding, owned by the Lippens family, made a famous deal by selling 25.8% of the shares it held. the French company Naturex, for a total amount of 330 million euros.

This is what our colleagues from L'Echo, who point out that this initiative is the result of a well-crafted strategy around taking stakes in the heart of a sugar market, thundered by

CEO Olivier Lippens declined to comment, but the annual report published by the Lippens Family Holding indicates that Finasucre has " a significant added value " and that 'he' will redeploy this sum by taking care to limit the risks of its cyclical activities and to create value in activities in sustainable growth ", as written L'Echo

It should be noted that the end of the European sugar quotas decreed last year have not been without consequences: the price of sugar has fallen – resulting in an excessive level of production on an international scale – and competition has become even more fiercely. In fact, the turnover of Finasucre suffered. L'Echo notes a decline of 14%, ie a decrease in turnover from 406.9 million (2016-2017) to 349.9 million last year.

Remains at where will these funds (330 million euros) from this Naturex operation be reinvested? The group has diversified operations in lactic acid production via Galactic, in real estate (Het Zoute Company among others) or in the field of bioplastics (Futerro). In short, various and varied activities could take advantage of this capital. In total, the group employs no less than 2,670 employees worldwide, concludes Echo.